Antares Pharma Financial Statements
Antares Pharma Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Antares Pharma Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 5.7 | 7.9 | 4.3 |
| Gross Profit ($ mil.) | 3.6 | 4.4 | 2.7 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (12.7) | (8.6) | (8.1) |
| Diluted EPS (Net Income) | (0.19) | (0.14) | (0.16) |
Antares Pharma Stock Quote & Chart
11/09/09 14:23:39 EST •
AMEX •
1.13
•
 -0.0074
•
-0.6506 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Antares Pharma Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 11.30 | 2.38 | 7.01 |
| Price/Earnings Ratio | (7.09) | 27.93 | 25.51 |
| Price/Book Ratio | 31.06 | 2.79 | 6.74 |
| Price/Cash Flow Ratio | (7.80) | 12.82 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Antares Pharma Financial Ratios
Antares Pharma Competitive Intelligence
| Bioject Medical | Elan | Medical House | |
|---|---|---|---|
| Annual Sales ($ mil.) | 6.5 | 1,000.2 | 4.2 |
| Employees | 33 | 1,687 | -- |
| Market Cap ($ mil.) | 2.6 | 3,101.9 | 16.2 |
Competitive Landscape
